Manchester mum only given months to live gets all-clear after breast cancer drug trial
51-year-old Jasmin David is receiving groundbreaking treatment at The Christie NHS Foundation Trust in Manchester.
A mum from Manchester who was told she only had months to live has now been given the breast cancer all-clear after a groundbreaking drug trial.
51-year-old Jasmin David from Fallowfield was a previously fit and healthy mother of two grown-up children, and was working as a clinical lead at a care home for the elderly, before she discovered that she had an aggressive triple negative form of breast cancer in November 2017 after finding a lump above the nipple.
Following her diagnosis, Jasmin then underwent six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy.
These treatments successfully cleared her body of cancer, but sadly, back in October 2019, the cancer returned, and scans showed multiple lesions throughout her body meaning she had a poor prognosis.
Jasmin then discovered that the cancer had unfortunately spread to the lungs, lymph nodes, and chest bone, and was given the devastating news that she had less than a year to live.
Two months later, and with no other options left, Jasmin was offered the opportunity to be part of research by participating in the first phase of a two-year groundbreaking clinical trial, which she accepted, and then in December 2019, began treatment at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust in Manchester.
During the trial, Jasmin is given an experimental medicine combined with Atezolizumab – an immunotherapy drug administered intravenously – which she continues to have every three weeks.
Jasmin says she feels “reborn” after beginning the treatment trial.
And she’s now showing no evidence of the disease, and enjoying life with her husband David and children Ryan and Riona.
“I was 15 months down the line after my initial cancer treatment and had almost forgotten about it, but then the cancer returned,” Jasmin explained.
“When I was offered the trial, I didn’t know if it would work for me, but I thought that at least I could do something to help others and use my body for the next generation. At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly – but then thankfully, I started to respond well to the treatment.
“I celebrated my 50th birthday in February 2020 while still in the middle of treatment and not knowing what the future held.
“Two and a half years ago, I thought it was the end – and I now feel like I’ve been reborn.”
By June 2021, scans showed no measurable cancer cells in Jasmin’s body and she was then declared cancer free, but will still remain on treatment until December 2023.
Professor Fiona Thistlethwaite, medical oncologist and clinical director of Manchester CRF at The Christie – who is leading on the study in the UK – said: “We are really pleased that Jasmin has had such a good outcome, and at The Christie, we are continually testing new drugs and therapies to see if they can benefit more people.”
Featured Image – The Christie NHS (via Jasmin David)